CLEVELAND, Jan. 4, 2018 /PRNewswire/ — As Centerline Biomedical, Inc. prepares to meet with investors, strategic partners and companies in the healthcare industry during the JP Morgan Healthcare Conference, it successfully completed a fifth preclinical study at Cleveland Clinic facilities evaluating its surgical navigation system, IOPS, the Intra-Operative Positioning System. This study […]
Peripheral/Endo
Peripheral Vascular Devices Market Worth 12.63 Billion USD by 2022
PUNE, India, January 4, 2018 /PRNewswire/ — According to a new market research “Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) – Global Forecast to 2022“, published by MarketsandMarkets™, the market is expected to reach USD 12.63 Billion by 2022 from USD 9.09 […]
First Patient Enrolled in Investigational Study of the GORE EXCLUDER Conformable AAA Endoprosthesis with ACTIVE CONTROL System
FLAGSTAFF, Ariz.–(BUSINESS WIRE)– W. L. Gore & Associates, Inc.(Gore) today announced the first implant of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the United States. The successful procedure took place on December 19, 2017 at Maimonides Medical Center in New York by Robert Rhee, MD, Chief of Vascular and Endovascular Surgery, and National […]
Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris
REDWOOD CITY, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) — Avinger(NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that Arne Schwindt, M.D., a vascular surgeon at St. Franziskus Hospital in Münster, Germany, has successfully treated the first seven patients with the next generation Pantheris Lumivascular atherectomy system. […]
Avinger Announces 510(k) Filing of Next Generation Pantheris Device
REDWOOD CITY, Calif., Dec. 21, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced the Company submitted a new 510(k) application to the U.S. Food & Drug Administration (FDA) for its next generation Pantheris® Lumivascular atherectomy system, the first-ever image-guided […]
Mentice Acquires Endovascular Business from Medical Simulation Corporation
GOTHENBURG, Sweden–(BUSINESS WIRE)–Mentice boosts its US development presence and adds a clinical training service line with the acquisition of Medical Simulation Corporation’s (MSC) Medical Products division. Mentice is the global leader of simulation-based performance solutions for endovascular therapies. Under the agreement, Mentice will acquire the assets of the MSC’s Medical […]
Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device
REDWOOD CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced Conformité Européenne (CE) Marking approval for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of PAD. The novel […]
XableCath Scores FDA Clearance for Broadly Effective Catheter
SALT LAKE CITY–(BUSINESS WIRE)– XableCath, a clinical stage medical device company, announced its XableCath blunt tip support catheter has received clearance from the FDA. The blunt tip catheter facilitates true lumen passage of lesions, both above and below the knee, in the peripheral vasculature. Procedures using the XableCath blunt tip catheters can […]
Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS® Therapy Protocols for Pulmonary Embolism
BOTHELL, Wash.–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the treatment of Pulmonary Embolism utilizing EKOS® therapy with faster, and even […]
Saranas Named Finalist for Prestigious International Cardiovascular Innovation Award
HOUSTON–(BUSINESS WIRE)–Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced the company was named as one of the Top 4 Innovators at the International Conference for Innovations in Cardiovascular Systems (ICI) in Tel Aviv, Israel. The ICI […]
Recent
VentureMed Strengthens Commercial Leadership and Expands Clinical Evidence to Drive FLEX Vessel Prep™ System Growth
Growing Market Applications, Centerline Biomedical Granted FDA 510(k) Clearance for IOPS® with New, Expanded Indication for Use
Rivus Pharmaceuticals Announces Publication of Phase 2a HuMAIN Trial of HU6 in Patients with Obesity-Related Heart Failure in JAMA Cardiology
Popular
- No commented posts yet